Company Performance - Bristol Myers Squibb (BMY) ended the recent trading session at $48.02, demonstrating a +2.85% change from the preceding day's closing price, outperforming the S&P 500 which registered a daily gain of 0.06% [1] - The stock has fallen by 0.49% in the past month, leading the Medical sector's loss of 1.83% and undershooting the S&P 500's gain of 5.88% [1] Earnings Forecast - The company is scheduled to release its earnings on July 31, 2025, with a predicted EPS of $1.17, indicating a 43.48% decline compared to the equivalent quarter last year [2] - The consensus estimate projects a revenue of $11.33 billion, reflecting a 7.1% fall from the equivalent quarter last year [2] Full Year Estimates - For the full year, the Zacks Consensus Estimates project earnings of $6.37 per share and a revenue of $46.26 billion, demonstrating changes of +453.91% and -4.23%, respectively, from the preceding year [3] Analyst Estimates - Recent modifications to analyst estimates for Bristol Myers Squibb indicate the ever-changing nature of near-term business trends, with positive estimate revisions being a sign of optimism about the business outlook [4] Zacks Rank and Valuation - The Zacks Rank system currently holds Bristol Myers Squibb at 3 (Hold), with the Zacks Consensus EPS estimate having moved 5.7% lower within the past month [6] - The company has a Forward P/E ratio of 7.33, indicating a discount compared to its industry's Forward P/E of 17.79 [7] PEG Ratio - Bristol Myers Squibb currently trades at a PEG ratio of 2.44, compared to the Medical - Biomedical and Genetics industry's average PEG ratio of 1.47 [8] Industry Ranking - The Medical - Biomedical and Genetics industry is part of the Medical sector, holding a Zacks Industry Rank of 95, placing it in the top 39% of all 250+ industries [9]

Core Viewpoint - Marvell Technology is expected to show significant year-over-year growth in its upcoming earnings report, with analysts forecasting earnings of $0.67 per share and revenue of $2.01 billion, indicating a strong performance outlook for the company [2][3]. Financial Performance - In the latest trading session, Marvell Technology closed at $71.99, reflecting a -1.46% change from the previous day, underperforming compared to the S&P 500's gain of 0.06% [1]. - The stock has increased by 3.22% over the past month, which is lower than the Computer and Technology sector's gain of 9.6% and the S&P 500's gain of 5.88% [1]. - For the entire year, the Zacks Consensus Estimates predict earnings of $2.79 per share and revenue of $8.22 billion, representing increases of +77.71% and +42.61% respectively compared to the previous year [3]. Analyst Estimates and Market Sentiment - Recent revisions to analyst estimates for Marvell Technology are crucial as they reflect the latest business trends, with positive revisions indicating optimism about the company's outlook [3][4]. - The Zacks Rank system, which evaluates estimate changes, currently ranks Marvell Technology at 3 (Hold), with the consensus EPS estimate remaining unchanged over the past month [5]. Valuation Metrics - Marvell Technology has a Forward P/E ratio of 26.16, which is lower than the industry average of 27.9, suggesting that the company is trading at a discount compared to its peers [6]. - The company also has a PEG ratio of 0.61, significantly below the industry average PEG ratio of 1.63, indicating favorable growth prospects relative to its valuation [7]. Industry Context - The Electronics - Semiconductors industry, to which Marvell Technology belongs, ranks in the top 24% of all industries according to the Zacks Industry Rank, which assesses the strength of industry groups based on the average Zacks Rank of individual stocks [8].

FSLR is also sporting a PEG ratio of 0.27. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. FSLR's PEG compares to its industry's average PEG of 0.70. Over the past 52 weeks, FSLR's PEG has been as high as 0.33 and as low as 0.15, with a median of 0.23. Finally, investors should note that FSLR has a P/CF ratio of 10.96. This metric takes into account a company's operating cash flow and can be used to find stocks that are unde ...

Core Viewpoint - Coterra Energy's stock has underperformed in recent trading sessions, with a notable decline in the past month, while upcoming earnings are anticipated to show significant growth in both EPS and revenue compared to the previous year [1][2][3]. Company Performance - Coterra Energy closed at $23.09, reflecting a -5.33% change from the previous day, underperforming against the S&P 500's gain of 0.14% [1]. - The stock has decreased by 9.57% over the past month, contrasting with the Oils-Energy sector's loss of 0.85% and the S&P 500's gain of 5.35% [1]. Upcoming Earnings - The company is set to announce its earnings on August 4, 2025, with an expected EPS of $0.45, indicating a growth of 21.62% year-over-year [2]. - Revenue is projected to reach $1.71 billion, reflecting a 34.45% increase compared to the same quarter last year [2]. Fiscal Year Estimates - For the entire fiscal year, earnings are estimated at $2.6 per share, with revenue expected to be $7.59 billion, representing increases of +54.76% and +39.07% respectively from the previous year [3]. Analyst Estimates - Recent changes in analyst estimates for Coterra Energy are crucial for investors, as positive revisions indicate optimism about the business outlook [4]. - The Zacks Rank system, which incorporates estimate changes, currently ranks Coterra Energy as 3 (Hold) [6]. Valuation Metrics - Coterra Energy has a Forward P/E ratio of 9.37, which is lower than the industry average of 10.74, suggesting a valuation discount [7]. - The company holds a PEG ratio of 0.32, significantly below the industry average PEG ratio of 1.45, indicating favorable growth expectations relative to its valuation [8]. Industry Context - The Oil and Gas - Exploration and Production - United States industry, to which Coterra Energy belongs, ranks in the bottom 37% of all industries according to the Zacks Industry Rank [9].

Group 1: Company Performance - Monday.com (MNDY) stock was down 2.76% at $283.74, underperforming the S&P 500's daily gain of 0.14% [1] - Prior to the recent trading session, MNDY shares had gained 4.04%, lagging behind the Computer and Technology sector's gain of 7.37% and the S&P 500's gain of 5.35% [1] Group 2: Upcoming Earnings - The upcoming earnings release is expected to show an EPS of $0.84, reflecting a 10.64% decrease from the same quarter last year [2] - Revenue is forecasted to be $293.15 million, indicating a 24.16% increase compared to the year-ago quarter [2] Group 3: Full-Year Estimates - Full-year Zacks Consensus Estimates predict earnings of $3.79 per share and revenue of $1.22 billion, representing year-over-year changes of +8.29% and +25.59%, respectively [3] - Recent adjustments to analyst estimates may indicate short-term business trends and positive revisions can signal optimism about the business outlook [3] Group 4: Valuation Metrics - Current valuation metrics show a Forward P/E ratio of 77.05, significantly higher than the industry average of 29.16, indicating that Monday.com is trading at a premium [6] - The PEG ratio stands at 30.57, compared to the Internet - Software industry average of 2.2, suggesting a high valuation relative to expected earnings growth [7] Group 5: Industry Ranking - The Internet - Software industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 79, placing it within the top 32% of over 250 industries [7] - The Zacks Industry Rank assesses the strength of industry groups, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [8]

Company Performance - Silicon Motion (SIMO) closed at $74.67, reflecting a +1.84% change from the previous day, outperforming the S&P 500's daily gain of 0.14% [1] - Prior to the latest trading session, shares had gained 4.8%, which lagged behind the Computer and Technology sector's gain of 7.37% and the S&P 500's gain of 5.35% [1] Upcoming Earnings - The upcoming earnings release is scheduled for July 30, 2025, with analysts expecting earnings of $0.52 per share, indicating a year-over-year decline of 45.83% [2] - Revenue is projected to be $180.4 million, representing a 14.37% decrease compared to the same quarter of the previous year [2] Full-Year Estimates - Zacks Consensus Estimates for the full year predict earnings of $3.41 per share and revenue of $815.03 million, reflecting year-over-year changes of -0.58% and +1.43%, respectively [3] - Recent changes in analyst estimates suggest a direct relationship with stock price performance, with positive revisions indicating analyst optimism [4] Zacks Rank and Valuation - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks Silicon Motion at 2 (Buy), with an average annual return of +25% for 1 ranked stocks since 1988 [5] - The Forward P/E ratio for Silicon Motion is 21.48, which is a premium compared to the industry average of 19.71, while the PEG ratio stands at 10.13, significantly higher than the industry average of 4.27 [6] Industry Overview - The Computer - Integrated Systems industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 50, placing it in the top 21% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Applied Materials (AMAT) closed the most recent trading day at $192.61, moving +1.14% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.14%. Meanwhile, the Dow experienced a drop of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.38%. Prior to today's trading, shares of the maker of chipmaking equipment had gained 12.38% outpaced the Computer and Technology sector's gain of 7.37% and the S&P 500's gain of 5.35%. Investors will be eagerl ...

In the latest close session, Constellation Energy Corporation (CEG) was down 1.1% at $317.88. This move lagged the S&P 500's daily gain of 0.14%. Elsewhere, the Dow saw a downswing of 0.04%, while the tech- heavy Nasdaq appreciated by 0.38%. Shares of the company witnessed a gain of 5.41% over the previous month, beating the performance of the Oils- Energy sector with its loss of 0.85%, and the S&P 500's gain of 5.35%. The upcoming earnings release of Constellation Energy Corporation will be of great intere ...

Company Performance - Clearway Energy (CWEN) closed at $32.98, marking a +1.95% move from the prior day, outperforming the S&P 500 which registered a daily loss of 0.01% [1] - The company has gained 0.81% in the past month, while the Oils-Energy sector lost 1.27% and the S&P 500 gained 5.37% [2] Earnings Forecast - Clearway Energy is expected to release its earnings on August 5, 2025, with a predicted EPS of $0.81, indicating an 88.37% growth compared to the same quarter last year [3] - The consensus estimate for quarterly revenue is $434.4 million, up 18.69% from the year-ago period [3] Annual Estimates - For the annual period, Zacks Consensus Estimates anticipate earnings of $1.21 per share and revenue of $1.46 billion, signifying shifts of +61.33% and +6.14% respectively from the last year [4] Analyst Estimates - Recent changes to analyst estimates for Clearway Energy should be noted, as positive revisions are interpreted as a good sign for the business outlook [4] - The Zacks Rank system indicates that Clearway Energy currently holds a Zacks Rank of 3 (Hold) [6] Valuation Metrics - Clearway Energy is currently traded at a Forward P/E ratio of 26.68, which is a premium compared to the industry average Forward P/E of 19.79 [7] - The company has a PEG ratio of 0.7, while the Alternative Energy - Other industry had an average PEG ratio of 2.4 [7] Industry Context - The Alternative Energy - Other industry, part of the Oils-Energy sector, ranks in the bottom 39% of all industries according to the Zacks Industry Rank [8] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Organon (OGN) shares decreased by 1.87% to $9.46, underperforming the S&P 500's slight loss of 0.01% on the same day [1] - Over the past month, Organon shares have declined by 2.43%, compared to a 1.59% loss in the Medical sector and a 5.37% gain in the S&P 500 [1] Upcoming Earnings - The upcoming earnings release is anticipated, with an expected EPS of $0.94, reflecting a 16.07% decrease from the same quarter last year [2] - Revenue is forecasted at $1.55 billion, indicating a 3.35% decline compared to the same quarter of the previous year [2] Fiscal Year Estimates - For the entire fiscal year, earnings are projected at $3.83 per share, representing a -6.81% change from the previous year [3] - Revenue for the fiscal year is estimated at $6.24 billion, showing a -2.48% change from the prior year [3] Analyst Estimates - Recent adjustments to analyst estimates for Organon reflect changing short-term business dynamics, with positive revisions indicating analysts' confidence in performance [4] - The Zacks Rank system, which incorporates estimate changes, suggests a correlation between these revisions and stock price performance [5] Zacks Rank and Valuation - Organon currently holds a Zacks Rank of 2 (Buy), with a 0.55% increase in the consensus EPS estimate over the past month [6] - The company is trading at a Forward P/E ratio of 2.52, significantly lower than the industry average of 15.4, indicating a discount [7] - Organon has a PEG ratio of 0.96, compared to the industry average of 1.52, suggesting favorable valuation relative to growth expectations [7] Industry Context - The Medical Services industry, part of the Medical sector, has a Zacks Industry Rank of 90, placing it in the top 37% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]